A pilot scale project on co-administration of mass annual single dose DEC(6mg/kg)+Albendazole(400mg) launched in the month of February 2001 in 9 districts with 6 districts in Tamil Nadu, 2 districts in Orissa and 1 district in Kerala covering a population of 20.54 million.
Mechanism of Drug Distribution:State governemnts are resposible for drug distribution. This was carried out by utilizing the existing health infrastructure of the respective stae governemnts, as well as through other governmental and non-governemntal agencies. Drug was distributed by door-to-door visit.
Ist round of Mass drug distribution of DEC+Albendazole carried out on 24th and 25th February 2001 in Kerala ( coverage details in Kerala)and in Tamil Nadu (6 districts) between 19th March to 24th March 2001.(Reported coverage details in Tamil Nadu )
Click for pilot scale project on DEC+Albendazole
i)Protocol
ii)Presentations
Why Dec+Albendazole?
Albendazole is one of the most widely used anti-parasite drugs for curing intestinal worm infections of children, and when co-administered as a single treatment with the anti-filarial drug DEC(6mg/kg), it also enhances the ability of these drugs to stop the spread of filarial infection.
| Activity | Time Schedule | Responsible agency | |
|---|---|---|---|
| From | To | ||
Sensitization and advocacy
|
November 2000 December 2000 December 2000 |
December 2000 | Programme Manager in collaboration with Research Institution |
| Micro-plan (implementation) preparation at district level | 15 12.2000 | 20.12.2000 | Programme manager at district level in collaboration with Research Institution |
Training/orientation (health staff)
| 4.12.2000 11.12.2000 4.12.2000 | 15.12.2000 20.12.2000 15.12.2000 | Research institution |
Training/orientation (Other sectors)
| FIRST WEEK OF FEBRUARY 2000 | SECOND WEEK OF FEBRUARY 2000 | Programme manager at district level in collaboration with Research Institution |
| Identification of villages/wards positive for microfilaraemia | 20.12.2000 | 15.1.2001 | Programme manager at district level in collaboration with Research Institution |
| Selection of sentinel villages/wards | 15.1.2001 | 20.1.2001 | VCRC |
| Collection of baseline data on mf prevalence and intensity, and antigeneamia prevalence in sentinel and spot-check villages/wards | 20.1.2001 | 15.2.2001 | Research Institution in collaboration with Programme manager |
| Collection of baseline data on entomological parameters in sentinel villages/wards | 15.1.2001 | 20.2.2001 | Programme manager/ Research Institution |
| Collection of baseline data on geo-helminth prevalence in sentinel and spot-check villages | 20.1.2001 | 10.2.2001 | Research Institution |
| Family Enumeration/ updating and &nbs p;morbidity survey | 1.1.2001 | 10.1.2001 | Programme manager |
| Drug request from PHC/district | 10.1.2001 | 15.1.2001 | Programme manager at PHC/ district level |
| Drug procurement and supply | 15.1.2001 | 15.2.2001 | Programme manager at state / district level |
| Community preparation (IEC campaign including planning) | 1.2.2001 | 15.2.2001 | Programme manager at state/district/PHC level in collaboration with Research Institution |
| Drug distribution | 19.3.2001 | 23.3.2001 | Programme manager |
| Active surveillance for adverse reaction | 23.3.2001 | 28.3.2001 | Programme manager |
| Serious Adverse Experience report | 19.3.12001 | 28.3.2001 | Programme manager |
| Compliance survey | 1.3.2001 | 10.3.2001 | Research Institution |
| Consolidation and reporting of drug distribution and coverage | 26.3.2001 | 1.4.2001 | Programme manager |